Skip to search formSkip to main contentSkip to account menu

santacruzamate A

Known as: ethyl 3-(phenethylcarbamoyl)propylcarbamate 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Carbamates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1 and p19INK4d upregulation in hepatocellular carcinoma
Histone deacetylases (HDACs) are commonly dysregulated in cancer and represent promising therapeutic targets. However, global… 
2018
2018
Synthesis, cytotoxic activity, and mode of action of new Santacruzamate A analogs
Breast and ovarian cancer are the most common cancers in women. Available cancer treatments, in general, have limited efficacy… 
2017
2017
Synthesis and biological evaluation of Santacruzamate-A based analogues.
2016
2016
Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.
2015
2015
Synthesis and biological evaluation of santacruzamate A and analogs as potential anticancer agents
Santacruzamate A, a recently discovered natural product from a Panamanian marine cyanobacterium Symploca sp., features a similar… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)